What is the Market's View on Atara Biotherapeutics Inc (ATRA) Stock's Price and Volume Trends Thursday?

Overall market sentiment has been high on Atara Biotherapeutics Inc (ATRA) stock lately. ATRA receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Atara Biotherapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ATRA!

See Full ATRA Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ATRA Stock Today?

Atara Biotherapeutics Inc (ATRA) stock is up 1.25% while the S&P 500 is down -0.89% as of 12:18 PM on Thursday, Jun 30. ATRA is up $0.10 from the previous closing price of $7.58 on volume of 710,813 shares. Over the past year the S&P 500 is lower by -11.81% while ATRA is down -50.58%. ATRA lost -$3.65 per share in the over the last 12 months. To screen for more stocks like Atara Biotherapeutics Inc click here.

More About Atara Biotherapeutics Inc

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs. Click Here to get the full Stock Report for Atara Biotherapeutics Inc stock.